Martha Morrell - 20 Feb 2023 Form 4 Insider Report for NeuroPace Inc (NPCE)

Role
Chief Medical Officer
Signature
/s/ Irina Ridley, Attorney-In-Fact
Issuer symbol
NPCE
Transactions as of
20 Feb 2023
Net transactions value
$0
Form type
4
Filing time
22 Feb 2023, 18:39:38 UTC
Previous filing
11 Oct 2022
Next filing
07 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NPCE Common Stock Award $0 +80,000 +140% $0.000000 137,164 20 Feb 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on February 20, 2024 and the remaining RSUs vest in eight (8) equal quarterly installments thereafter.